Principal Financial Group Inc. Sells 27,903 Shares of Stryker Corporation $SYK

Key Points

• Principal Financial Group reduced its Stryker stake by 5.5%, selling 27,903 shares and retaining 480,116 shares valued at approximately $151.2 million. Institutional investors collectively own 77.09% of Stryker.
• Stryker reported quarterly earnings of $3.69 per share, exceeding estimates of $3.49, while revenue rose 9.4% year over year to $6.59 billion. The company issued fiscal 2026 EPS guidance of $14.95–$15.10.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $386.28, compared with the stock’s reported price of $338.80. Stryker also announced a quarterly dividend of $0.88 per share, representing a 1.0% annualized yield.

Principal Financial Group Inc. reduced its stake in Stryker Corporation (NYSE:SYK - Free Report) by 5.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 480,116 shares of the medical technology company's stock after selling 27,903 shares during the quarter. Principal Financial Group Inc. owned about 0.13% of Stryker worth $151,160,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of SYK. Varma Mutual Pension Insurance Co increased its position in Stryker by 10.5% during the 4th quarter. Varma Mutual Pension Insurance Co now owns 53,610 shares of the medical technology company's stock valued at $18,842,000 after purchasing an additional 5,100 shares during the period. QRG Capital Management Inc. increased its stake in shares of Stryker by 7.4% during the fourth quarter. QRG Capital Management Inc. now owns 60,548 shares of the medical technology company's stock valued at $21,281,000 after purchasing an additional 4,186 shares in the last quarter. Swedbank AB increased its position in Stryker by 6.6% during the 4th quarter. Swedbank AB now owns 129,027 shares of the medical technology company's stock valued at $45,349,000 after buying an additional 7,934 shares in the last quarter. Crossmark Global Holdings Inc. raised its stake in Stryker by 31.1% during the fourth quarter. Crossmark Global Holdings Inc. now owns 26,820 shares of the medical technology company's stock valued at $9,426,000 after buying an additional 6,367 shares during the last quarter. Finally, Royal Bank of Canada raised its holdings in Stryker by 6.5% in the first quarter. Royal Bank of Canada now owns 3,273,232 shares of the medical technology company's stock worth $1,075,552,000 after buying an additional 199,863 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company's stock.

Wall Street Analyst Weigh In

SYK has been the subject of a number of research reports. Weiss Ratings reiterated a "hold (c)" rating on shares of Stryker in a research report on Friday, July 31st. Evercore set a $350.00 price objective on Stryker in a research report on Monday, July 6th. Leerink Partners decreased their price target on shares of Stryker from $410.00 to $407.00 and set an "outperform" rating on the stock in a research note on Friday, June 5th. Wells Fargo & Company reduced their target price on shares of Stryker from $456.00 to $418.00 and set an "overweight" rating on the stock in a research note on Friday, May 1st. Finally, Citizens Jmp cut their price objective on Stryker from $440.00 to $400.00 and set a "market outperform" rating on the stock in a research report on Monday, August 3rd. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Stryker currently has a consensus rating of "Moderate Buy" and a consensus price target of $386.28.

Stryker Trading Down 0.7%

Stryker stock opened at $338.80 on Friday. The firm has a market cap of $129.95 billion, a PE ratio of 35.11, a P/E/G ratio of 2.16 and a beta of 0.76. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $396.86. The stock's 50 day simple moving average is $324.61 and its two-hundred day simple moving average is $333.57. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, topping analysts' consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company had revenue of $6.59 billion during the quarter, compared to analysts' expectations of $6.58 billion. During the same quarter in the prior year, the firm posted $3.13 EPS. Stryker's quarterly revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker's dividend payout ratio (DPR) is 36.48%.

Insider Transactions at Stryker

In other news, VP Robert S. Fletcher sold 4,544 shares of Stryker stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $306.87, for a total value of $1,394,417.28. Following the completion of the sale, the vice president directly owned 10,582 shares of the company's stock, valued at approximately $3,247,298.34. The trade was a 30.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of the company's stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total value of $96,791,300.00. Following the sale, the director owned 1,924,880 shares in the company, valued at approximately $601,005,282.40. This trade represents a 13.87% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 4.60% of the stock is owned by company insiders.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source